[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
about
Update on positron emission tomography for imaging of prostate cancerPET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-cholineAdvanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy.Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.Targeted prostate biopsy and MR-guided therapy for prostate cancer.Functional imaging for prostate cancer: therapeutic implications.Molecular imaging of prostate cancer: PET radiotracers.Choline autoradiography of human prostate cancer xenograft: effect of castrationRapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.Comparison between kinetic modelling and graphical analysis for the quantification of [18F]fluoromethylcholine uptake in mice.Diagnostic evaluation of PSA recurrence and review of hormonal management after radical prostatectomy.Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.Modalities for imaging of prostate cancer.Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancerLymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Imaging treated prostate cancer.Choline PET/CT for imaging prostate cancer: an update.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.Choline PET based dose-painting in prostate cancer--modelling of dose effectsImaging of prostate cancer with PET/CT using (18)F-Fluorocholine.MRI-Guided Prostate Biopsy of Native and Recurrent Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Detection of aggressive primary prostate cancer with 11C-choline PET/CT using multimodality fusion techniques.Optimising (18)F-Choline PET/CT Acquisition Protocol in Prostate Cancer Patients.Delineation of the Prostate Bed: The "Invisible Target" Is Still an Issue?Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness.Study of inter- and intra-observer reproducibility in the interpretation of [(18)F]choline PET/CT examinations in patients suffering from biochemically recurrent prostate cancer following curative treatment.An Incidental Finding of Mucinous Colon Cancer by (18)F-Choline PET/CT Determining a Change in Clinical Management of a Patient with Recurrent Prostate Adenocarcinoma.Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer.Clinical utility of (18)F-fluorocholine positron-emission tomography/computed tomography (PET/CT) in biochemical relapse of prostate cancer after radical treatment: results of a multicentre study.Influence of androgen deprivation therapy on choline PET/CT in recurrent prostate cancer.Role of ¹⁸F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer.Adenocarcinoma of the prostate involving the lumbosacral plexus: MRI evidence to support direct perineural spread.The use of PET/CT in prostate cancer.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Detection of local recurrence of prostate cancer after radical prostatectomy: Is there a role for early ¹⁸F-FCH PET/CT?
P2860
Q27026828-0A221994-9024-4B36-8FF1-C9550AF5CB62Q31003607-97FA90C8-297E-458A-B46A-867A327D9C36Q33583831-F70196EE-A474-44EB-A3E5-CE58770E5B9FQ34448553-86D118F9-1013-42B6-8B4D-73377B792966Q35155500-8A0D45C4-BD78-4A69-9056-7EF5F953B0A8Q35195300-CFCA4381-1DAA-471B-97B8-00AED2953164Q35933229-A458973E-6E84-4487-BDFD-2842DC8C4A7AQ36128629-04CF0894-3B26-4B8F-8518-6CAE7E5A8EA8Q36129937-0C6E8D10-10D6-46C6-9DE1-CBB73A51E2B3Q37052606-B0D6E110-E83A-4970-9E7A-EFEC88D27E0AQ37357942-345C50EC-9F3E-477D-85AC-0DEB58127846Q37359926-75337BC2-B11A-40FE-BFE2-F16D435A8F8EQ37399907-4D755344-275A-48F1-99B6-6C287E1EA0E0Q37457888-849E5F38-60DC-4D75-8D1D-29AB14BA2B78Q37719273-A13F949E-CD80-4801-8854-9C2B2E85CBCCQ37972920-8D564928-607F-401E-9FC9-A0FCA84BB71FQ37973351-8C197202-26EF-4381-A897-D1EE8486C317Q38098441-BA343540-ACF6-405C-AA4F-09FE16B01A28Q38100661-E635228C-3168-411B-8E39-CCC8D297568BQ38103180-C67CB197-66F7-4F68-AFC3-638A275BF5CEQ38190115-83D8E723-EBC5-4CD3-8BCC-EE5B7CD38DC9Q38445916-3C46557C-222E-427B-81D9-60182A0D8E0FQ38479113-9996B35D-A62B-45E3-A986-F38FB88512AAQ38943188-F15B4780-1550-4175-A39C-F3E4567E004BQ39242140-46DF5C8D-8BCC-4840-9467-FB9A021954E6Q39601617-805A2BB7-E7C7-4B62-A8C0-5DFE6451CE4DQ42128105-449F3E3A-2C42-4650-9075-CE100C505B33Q42236979-1CDBEDA5-9365-4F16-BA75-65ED5A7D8841Q42423216-9DB293B8-3B29-4658-A884-25A4AFC4835DQ42716680-D0E6851C-5184-47FE-9B1A-5A7AB502CC22Q42843725-AD549EFD-B69A-40DC-85DA-6D8C0314A360Q43437979-46E68759-5001-4E9F-8A08-603EC6B49A38Q45038526-A71CACF1-608B-4A61-B2F0-DF7F39F07B71Q45346212-C31365C2-25DB-417B-A625-710D440DE9F4Q45384878-41A0B3DB-F934-4940-B8EC-0F63064446E6Q45760116-0EFA2950-357B-42DD-9FFA-EA231A32BA81Q45787648-A2CAC504-3969-4284-AF66-5472B972AB1AQ49919217-B72AAE7D-6BA1-4C8A-A532-075CBA555F74Q52990619-A6D4C39A-A4CD-4FD1-B06A-319B65550B7CQ52991811-C75687EC-F06B-4B8F-B14D-BD9BBA981814
P2860
[11C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@ast
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@en
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@nl
type
label
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@ast
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@en
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@nl
prefLabel
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@ast
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@en
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@nl
P1476
[11C]choline PET/CT imaging in ...... r after radical prostatectomy.
@en
P2093
Norbert M Blumstein
Sven N Reske
P2888
P356
10.1007/S00259-007-0530-2
P577
2007-09-09T00:00:00Z